• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经动脉栓塞治疗后肝癌患者外在凋亡途径活性增加。

Increased extrinsic apoptotic pathway activity in patients with hepatocellular carcinoma following transarterial embolization.

机构信息

Division of General Surgery, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, College of Medicine, Kaohsiung 83301, Taiwan.

出版信息

World J Gastroenterol. 2011 Nov 14;17(42):4675-81. doi: 10.3748/wjg.v17.i42.4675.

DOI:10.3748/wjg.v17.i42.4675
PMID:22180709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3233673/
Abstract

AIM

To determine the apoptosis pathway in residual viable hepatocellular carcinoma (HCC) tissues following transarterial embolization (TAE).

METHODS

Ten patients with HCC who received surgical resection after TAE were enrolled in the study group, and 24 patients with HCC who received surgical resection only served as the control group. In the study group, we measured the changes in tumor size and α fetoprotein (AFP) levels after TAE. All tissue samples were taken from the residual tumors. The expression of various apoptotic proteins was evaluated via immunoblotting procedures. The results were analyzed using a Student's t test.

RESULTS

Tumor size and the AFP level decreased by 46.2% and 55.3% after TAE, respectively. There was no significant difference detected for the Bcl-2/Bax ratio or the cleaved caspase-9 expression levels in either group. However, extrinsic apoptopic pathway-related expression of Fas and cleaved caspase-8 expression were significantly higher in the study group than in the control group (P < 0.05). In addition, cleaved caspase-3 expression in the study group was higher (1.62-fold) than in control group (P < 0.05).

CONCLUSION

TAE is an effective palliative therapy that decreases tumor size and AFP levels via an increase in extrinsic apoptosis pathway in patients with unresectable HCC.

摘要

目的

确定经动脉栓塞(TAE)后残余存活肝细胞癌(HCC)组织中的细胞凋亡途径。

方法

研究组纳入 10 例接受 TAE 后手术切除的 HCC 患者,对照组纳入 24 例仅接受手术切除的 HCC 患者。在研究组中,我们测量 TAE 后肿瘤大小和α胎蛋白(AFP)水平的变化。所有组织样本均取自残余肿瘤。通过免疫印迹程序评估各种凋亡蛋白的表达。采用Student's t 检验进行分析。

结果

TAE 后肿瘤大小和 AFP 水平分别降低了 46.2%和 55.3%。两组的 Bcl-2/Bax 比值或 cleaved caspase-9 表达水平均无显著差异。然而,研究组中 Fas 和 cleaved caspase-8 的外源性凋亡途径相关表达明显高于对照组(P<0.05)。此外,研究组的 cleaved caspase-3 表达(1.62 倍)高于对照组(P<0.05)。

结论

TAE 是一种有效的姑息治疗方法,通过增加不可切除 HCC 患者的外源性凋亡途径,可降低肿瘤大小和 AFP 水平。

相似文献

1
Increased extrinsic apoptotic pathway activity in patients with hepatocellular carcinoma following transarterial embolization.经动脉栓塞治疗后肝癌患者外在凋亡途径活性增加。
World J Gastroenterol. 2011 Nov 14;17(42):4675-81. doi: 10.3748/wjg.v17.i42.4675.
2
Transarterial embolization/chemoembolization therapy for hepatocellular carcinoma fed by adrenal artery: Preliminary results.经动脉栓塞/化疗栓塞治疗肾上腺动脉供血的肝细胞癌:初步结果。
Medicine (Baltimore). 2016 Dec;95(52):e5762. doi: 10.1097/MD.0000000000005762.
3
Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.经导管肝动脉栓塞术后的肝细胞癌。84例切除病例的组织病理学研究。
Cancer. 1994 May 1;73(9):2259-67. doi: 10.1002/1097-0142(19940501)73:9<2259::aid-cncr2820730905>3.0.co;2-p.
4
Supplemental conventional transarterial embolization/chemoembolization therapy via extrahepatic arteries for hepatocellular carcinoma.经肝外动脉对肝细胞癌进行补充性传统经动脉栓塞/化疗栓塞治疗。
J Cancer Res Ther. 2017;13(4):720-724. doi: 10.4103/jcrt.JCRT_993_16.
5
NET-1 promotes invasion, adhesion and growth of hepatocellular carcinoma by regulating the expression of BAX, caspase 3, caspase 8 and BCL2.NET-1通过调节BAX、半胱天冬酶3、半胱天冬酶8和BCL2的表达来促进肝细胞癌的侵袭、黏附和生长。
Cell Mol Biol (Noisy-le-grand). 2018 Sep 30;64(12):37-41.
6
Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma.实时定量检测甲胎蛋白信使核糖核酸以评估肝细胞癌经动脉化疗栓塞术后的血行播散情况
Ann Surg. 2003 Aug;238(2):241-8. doi: 10.1097/01.sla.0000080959.95226.be.
7
Initial Alpha-Fetoprotein Response Predicts Prognosis in Hepatitis B-related Solitary HCC Patients After Radiofrequency Ablation.初始甲胎蛋白反应可预测乙型肝炎相关孤立性肝癌患者射频消融后的预后。
J Clin Gastroenterol. 2018 Mar;52(3):e18-e26. doi: 10.1097/MCG.0000000000000841.
8
Clinical significance of mrp gene in primary hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int. 2003 Aug;2(3):397-403.
9
Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatment.121例有或无治疗史的不可切除肝细胞癌患者经导管动脉栓塞后的预后
World J Gastroenterol. 2006 Apr 7;12(13):2075-9. doi: 10.3748/wjg.v12.i13.2075.
10
Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms.藜芦醇对二乙基亚硝胺诱导的大鼠肝癌的保护作用及其机制。
Eur J Pharmacol. 2016 Aug 5;784:173-80. doi: 10.1016/j.ejphar.2016.04.045. Epub 2016 May 12.

引用本文的文献

1
Can heme oxygenase-1 be a prognostic factor in patients with hepatocellular carcinoma?血红素加氧酶-1能否作为肝细胞癌患者的预后因素?
Medicine (Baltimore). 2019 Jun;98(26):e16084. doi: 10.1097/MD.0000000000016084.
2
Expression and potential roles of sodium-potassium ATPase and E-cadherin in human gastric adenocarcinoma.钠钾ATP酶和E-钙黏蛋白在人胃腺癌中的表达及潜在作用
PLoS One. 2017 Aug 23;12(8):e0183692. doi: 10.1371/journal.pone.0183692. eCollection 2017.
3
Hepatocellular carcinoma in patients with chronic kidney disease.慢性肾脏病患者的肝细胞癌。
World J Gastroenterol. 2013 Apr 28;19(16):2466-72. doi: 10.3748/wjg.v19.i16.2466.

本文引用的文献

1
Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.经动脉化疗栓塞术、经动脉化疗和经动脉化疗治疗肝细胞癌。
Semin Oncol. 2010 Apr;37(2):89-93. doi: 10.1053/j.seminoncol.2010.03.007.
2
Involved intrinsic apoptotic pathway in the varicocele and varicose veins.精索静脉曲张和静脉曲张中涉及的内源性凋亡途径。
Ann Vasc Surg. 2010 Aug;24(6):768-74. doi: 10.1016/j.avsg.2010.02.018. Epub 2010 May 13.
3
Intra-arterial therapies for hepatocellular carcinoma: where do we stand?经动脉治疗肝细胞癌:我们处于什么位置?
Ann Surg Oncol. 2010 May;17(5):1234-46. doi: 10.1245/s10434-010-0977-4. Epub 2010 Apr 20.
4
Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.经动脉化疗栓塞术联合经皮消融治疗不可切除肝细胞癌:一项荟萃分析。
Liver Int. 2010 May;30(5):741-9. doi: 10.1111/j.1478-3231.2010.02221.x. Epub 2010 Mar 18.
5
Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions.不可切除肝细胞癌的经导管化疗栓塞:当前认知与未来方向
Dig Dis. 2009;27(2):157-63. doi: 10.1159/000218348. Epub 2009 Jun 22.
6
Involved intrinsic apoptotic pathway of testicular tissues in varicocele-induced rats.精索静脉曲张诱导的大鼠睾丸组织中涉及的内源性凋亡途径。
World J Urol. 2009 Aug;27(4):527-32. doi: 10.1007/s00345-008-0367-8. Epub 2009 Jan 15.
7
TACE versus TAE as therapy for hepatocellular carcinoma.经动脉化疗栓塞术与经动脉栓塞术治疗肝细胞癌的比较
Expert Rev Anticancer Ther. 2008 Oct;8(10):1623-41. doi: 10.1586/14737140.8.10.1623.
8
Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications.经动脉化疗栓塞治疗肝细胞癌的综述:姑息性、联合性、新辅助性、桥接性和症状性适应证。
Eur J Radiol. 2009 Dec;72(3):505-16. doi: 10.1016/j.ejrad.2008.08.007. Epub 2008 Oct 2.
9
Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.低剂量与高剂量术前化疗栓塞后肝细胞癌中的坏死与凋亡
Cardiovasc Intervent Radiol. 2008 Nov-Dec;31(6):1133-40. doi: 10.1007/s00270-008-9379-4. Epub 2008 Jun 27.
10
Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization.经导管动脉化疗栓塞术后肝细胞癌中血管内皮生长因子表达增加。
Acta Radiol. 2008 Jun;49(5):523-9. doi: 10.1080/02841850801958890.